Home › Compare › CYTHW vs GBDC

CYTHW vs GBDC: Dividend Comparison 2026

CYTHW yields 6250.00% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYTHW wins by $547038161900801.38M in total portfolio value
10 years
CYTHW
CYTHW
● Live price
6250.00%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$547038161900822.19M
Annual income
$530,345,833,482,145,900,000.00
Full CYTHW calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — CYTHW vs GBDC

📍 CYTHW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYTHWGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYTHW + GBDC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CYTHW pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYTHW
Annual income on $10K today (after 15% tax)
$531,250.00/yr
After 10yr DRIP, annual income (after tax)
$450,793,958,459,824,000,000.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, CYTHW beats the other by $450,793,958,459,810,050,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYTHW + GBDC for your $10,000?

CYTHW: 50%GBDC: 50%
100% GBDC50/50100% CYTHW
Portfolio after 10yr
$273519080950421.53M
Annual income
$265,172,916,741,081,170,000.00/yr
Blended yield
96.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

CYTHW
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-46.3
Piotroski
2/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYTHW buys
0
GBDC buys
0
No recent congressional trades found for CYTHW or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYTHWGBDC
Forward yield6250.00% ✓11.86%
Annual dividend / share$2.00 ✓$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1% ✓
Portfolio after 10y$547038161900822.19M ✓$20.85M
Annual income after 10y$530,345,833,482,145,900,000.00 ✓$16,450,733.83
Total dividends collected$545916230838674.88M ✓$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusBuyBuy

Year-by-year: CYTHW vs GBDC ($10,000, DRIP)

YearCYTHW PortfolioCYTHW Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$635,700$625,000.00$12,492$1,791.70+$623.2K → CYTHW
2$37,812,208$37,132,009.35$16,527$3,160.58+$37.80M → CYTHW
3$2,104,624,511$2,064,165,448.17$23,588$5,904.90+$2104.60M → CYTHW
4$109,626,980,731$107,375,032,504.06$37,141$11,901.65+$109626.94M → CYTHW
5$5,344,419,538,811$5,227,118,669,428.94$66,205$26,463.38+$5344419.47M → CYTHW
6$243,874,608,189,950$238,156,079,283,422.40$137,452$66,612.65+$243874608.05M → CYTHW
7$10,417,442,627,867,752$10,156,496,797,104,504.00$342,372$195,298.53+$10417442627.53M → CYTHW
8$416,612,895,336,954,560$405,466,231,725,136,060.00$1,053,292$686,954.33+$416612895335.90M → CYTHW
9$15,600,306,933,342,350,000$15,154,531,135,331,807,000.00$4,111,439$2,984,416.95+$15600306933338.24M → CYTHW
10$547,038,161,900,822,200,000$530,345,833,482,145,900,000.00$20,849,974$16,450,733.83+$547038161900801.38M → CYTHW

CYTHW vs GBDC: Complete Analysis 2026

CYTHW — Stock

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.

Full CYTHW Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this CYTHW vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYTHW vs SCHDCYTHW vs JEPICYTHW vs OCYTHW vs KOCYTHW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.